Počet záznamov: 1
karmustín
SYS d002330 LBL 00000nx--j22000003--45-- 005 20240119200902.3 100 $a 19990101csloy0103----ba0 152 $b mesh 250 $a karmustín $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 300 1-
$a 73(72) $8 eng 300 1-
$a Alkylating Agents (1966-1971) $8 eng 300 1-
$a Nitroso Compounds (1966-1971) $8 eng 300 1-
$a Urea (1966-1971) $8 eng 330 1-
$a A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed) $8 eng 450 $a BCNU $5 e $8 eng 550 $3 sllk_un_auth*d018906 $Y Antineoplastic Agents, Alkylating $5 P $a antineoplastiká alkylačné 686 $a D02.065.950.594.247 686 $a D02.654.692.247 750 $a Carmustine $8 eng 801 -0
$a US $b DNLM $c 19990101 801 -2
$a SK $b BA006 $c 20070706 980 $x M
Počet záznamov: 1